Skip to content
Biotron Limited
  • Home
  • About Us
    • Board of Directors
    • Management Team
  • Technology
    • Clinical programs
    • Non-clinical programs
    • Intellectual property
  • News/Resources
    • Newsletters
    • In the news
    • Scientific Presentations
    • Scientific Publications
  • Investor Centre
    • ASX Announcements
    • Financial Reports
      • Annual
      • Half-year
      • Quarterly
    • Corporate Directory
    • Shareholder services
    • Options Exercise Instructions
    • Top 40 Shareholders
    • Corporate Governance
    • Corporate Presentations
  • Contacts

Year End Accounts and Preliminary Final Report for year ended 30 June 2008

30 April 201329 August 2008 by Karen Mobbs

Year End Accounts and Preliminary Final Report for year ended 30 June 2008

Categories 2008
Post navigation
Biotron Expands HCV Clinical Trial to a Second Site
BIT225 Highly Synergistic with New Class of Anti-HCV Therapies
© Biotron Limited 2016       ABN 60 086 399 144        Site updated 7 January 2021        Legal Notices and Privacy